EMEA-000482-PIP01-08-M04

Key facts

Invented name
Revestive
Active substance
teduglutide
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0351/2017
PIP number
EMEA-000482-PIP01-08-M04
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of short bowel syndrome
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Shire Pharmaceuticals Ireland Limited
Tel. +44 (0)8008 38470
E-mail: medinfoeuceemea@shire.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating